Real World Evidence of the Efficacy and Safety of FOQUEST

Clinical trial NCT04152629 · COMPLETED

Trial details

NCT number: NCT04152629
Sponsor: Purdue Pharma, Canada
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Attention Deficit-Hyperactivity Disorder

Start date: 2019-09-19
Primary completion: 2021-07-09
Enrollment: 257

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.